139 related articles for article (PubMed ID: 33041305)
1. Investigation of Related Impurities in Metadoxine by a Reversed Phase High Performance Liquid Chromatography Technique.
Suresh Babu K; Paradesi D
Anal Sci; 2021 Apr; 37(4):581-584. PubMed ID: 33041305
[TBL] [Abstract][Full Text] [Related]
2. Characterization of unknown impurities in Coenzyme Q
Deng Y; Chen X; Wang L; Peng X; Lin M
J Pharm Biomed Anal; 2019 Oct; 175():112771. PubMed ID: 31330281
[TBL] [Abstract][Full Text] [Related]
3. Separation and characterization of the polymerized impurities in oxacillin sodium by 2D HPSEC and HPLC IT-TOF MS.
Gao J; Wang F; Zhang X; Zhu B; Chen X; Li P; Zhou P; Zheng J; Wang J
Rapid Commun Mass Spectrom; 2023 Apr; 37(7):e9466. PubMed ID: 36597914
[TBL] [Abstract][Full Text] [Related]
4. Development of RP UPLC-TOF/MS, stability indicating method for omeprazole and its related substances by applying two level factorial design; and identification and synthesis of non-pharmacopoeial impurities.
Jadhav SB; Kumar CK; Bandichhor R; Bhosale PN
J Pharm Biomed Anal; 2016 Jan; 118():370-379. PubMed ID: 26600119
[TBL] [Abstract][Full Text] [Related]
5. [Identification of the impurity in auramine O by high performance liquid chromatography-ion trap-time of flight mass spectrometry and preparation of the auramine O reference standard by preparative high performance liquid chromatography].
Che F; Lu Y; Xi X; Lan T; Wei Y
Se Pu; 2019 Mar; 37(3):299-304. PubMed ID: 30900859
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the polymerized impurities in cefmetazole sodium based on novel separation principle by liquid chromatography tandem ion trap/time-of-flight mass spectrometry.
Wang F; Ren X; Zhu B; Zhang F; Gao J; Hong L; Wang J
J Pharm Biomed Anal; 2022 Jun; 215():114790. PubMed ID: 35483231
[TBL] [Abstract][Full Text] [Related]
7. Application of stability-indicating HPTLC method for quantitative determination of metadoxine in pharmaceutical dosage form.
Kaul N; Agrawal H; Patil B; Kakad A; Dhaneshwar SR
Farmaco; 2005 Apr; 60(4):351-60. PubMed ID: 15848212
[TBL] [Abstract][Full Text] [Related]
8. Separation and characterization of allergic polymerized impurities in cephalosporins by 2D-HPSEC×LC-IT-TOF MS.
Xu Y; Wang D; Tang L; Wang J
J Pharm Biomed Anal; 2017 Oct; 145():742-750. PubMed ID: 28806571
[TBL] [Abstract][Full Text] [Related]
9. Separation and characterization of allergenic polymerized impurities from cephalosporin for injection by trap free two-dimensional high performance size exclusion chromatography × reversed phase liquid chromatography coupled with ion trap time-of-flight mass spectrometry.
Xu Y; Wang D; Zhu B; Tang L; Wang J
J Pharm Biomed Anal; 2018 May; 154():425-432. PubMed ID: 29579634
[TBL] [Abstract][Full Text] [Related]
10. [Identification of the impurities in
Ma X; Jin L; Li Y; Zheng H; Wei Y
Se Pu; 2018 Mar; 36(3):268-277. PubMed ID: 30136505
[TBL] [Abstract][Full Text] [Related]
11. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
12. Study on the impurity profiles of cloxacillin and flucloxacillin based on liquid chromatography tandem ion trap/time-of-flight mass spectrometry.
Xu B; Gao J; Wang J; Wang F
Rapid Commun Mass Spectrom; 2024 Aug; 38(16):e9840. PubMed ID: 38890553
[TBL] [Abstract][Full Text] [Related]
13. Investigation of amodiaquine bulk drug impurities by liquid chromatography/ion trap mass spectrometry.
Dongre VG; Karmuse PP; Ghugare PD; Kanojiya SK; Rawal S
Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2227-33. PubMed ID: 18543378
[TBL] [Abstract][Full Text] [Related]
14. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
[TBL] [Abstract][Full Text] [Related]
15. Stability-Indicating RP-HPLC Method for the Estimation of Process-Related Impurities and Degradation Products in Fesoterodine Fumarate by Using a Mass Spectrometric Compatible Mobile Phase.
Kumar N; Sangeetha D; Kalyanraman L
J Chromatogr Sci; 2021 Jan; 59(2):154-164. PubMed ID: 33190158
[TBL] [Abstract][Full Text] [Related]
16. Identification and Characterization of Asulam Impurities in Self Made Bulk Batch Synthesis and Quantification by RP-HPLC Method.
Mahaboob Basha D; Venkata Reddy G; Gopi Krishna Y; Kumara Swamy BE; Vijay R
J AOAC Int; 2018 Sep; 101(5):1448-1460. PubMed ID: 29673416
[TBL] [Abstract][Full Text] [Related]
17. [Reversed-phase liquid chromatography separation and mass spectrometry fragmentation analysis of mitiglinide and three isomers].
Li M; Liu H; Hou J; Wang C; Li W; Che B
Se Pu; 2019 Apr; 37(4):412-417. PubMed ID: 30977344
[TBL] [Abstract][Full Text] [Related]
18. Application of a trap-free two-dimensional liquid chromatography combined with ion trap/time-of-flight mass spectrometry for separation and characterization of impurities and isomers in cefpiramide.
Wang J; Xu Y; Wen C; Wang Z
Anal Chim Acta; 2017 Nov; 992():42-54. PubMed ID: 29054149
[TBL] [Abstract][Full Text] [Related]
19. [Identification of impurity peaks in the HPLC chromatogram by LC-MS and two-dimensional chromatographic correlation spectroscopy].
Chen ZZ; Zhang DS; Wang N; Feng F; Hu CQ
Yao Xue Xue Bao; 2012 Apr; 47(4):492-7. PubMed ID: 22799032
[TBL] [Abstract][Full Text] [Related]
20. A novel two-dimensional liquid chromatography - Mass spectrometry method for direct drug impurity identification from HPLC eluent containing ion-pairing reagent in mobile phases.
Long Z; Zhan Z; Guo Z; Li Y; Yao J; Ji F; Li C; Zheng X; Ren B; Huang T
Anal Chim Acta; 2019 Feb; 1049():105-114. PubMed ID: 30612641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
